UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses on Their Investment in Delcath Systems, Inc. of Class Action

UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors With Losses on Their
Investment in Delcath Systems, Inc. of Class Action Lawsuit and the Deadline
of July 8, 2013 to Seek a Lead Plaintiff Position

NEW YORK, July 1, 2013 (GLOBE NEWSWIRE) -- Levi & Korsinsky announces that a
class action lawsuit has been commenced in the United States District Court
for the Southern District of New York on behalf of investors who purchased
Delcath Systems, Inc. ("Delcath" or the "Company") (Nasdaq:DCTH) stock between
April 21, 2010 through May 2, 2013.

For more information, click here: http://zlk.9nl.com/delcath-systems-dcth/.

The complaint alleges that during the Class Period, Delcath Systems made false
and/or misleading statements and/or failed to disclose that: (a) the Company's
Melblez Kit for the treatment of patients with unresectable ocular melanoma
metastatic to the liver included the risk of severe toxicity and death as a
result of patient's adverse reactions to the drug; and (b) the Company's
manufacturing facilities were in violation of Current Good Manufacturing

On April 30, 2013, the FDA published documents revealing that 7% of the 122
patients treated with the Melblez Kit had died as a result of the treatment.
On this news, shares of Delcath fell more than 40 percent. Then, on May 2,
2013, the Company announced that the ODAC voted unanimously that the benefits
of the Kit did not outweigh the risks associated with the procedure. Upon this
news, shares of Delcath System's fell further, to close at $0.46 per share the
following day.

If you suffered a loss in Delcath Systems you have until July 8, 2013 to
request that the Court appoint you as lead plaintiff. Your ability to share in
any recovery doesn't require that you serve as a lead plaintiff. To obtain
additional information, contact Joseph E. Levi, Esq. either via email at
jlevi@zlk.com or by telephone at (877) 363-5972, or visit

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and
Washington D.C. The firm has extensive expertise in prosecuting securities
litigation involving financial fraud, representing investors throughout the
nation in securities and shareholder lawsuits. Attorney advertising. Prior
results do not guarantee similar outcomes.

CONTACT: Levi & Korsinsky, LLP
         Joseph Levi, Esq.
         Eduard Korsinsky, Esq.
         30 Broad Street - 24th Floor
         New York, NY 10004
         Tel: (212) 363-7500
         Toll Free:  (877) 363-5972
         Fax: (866) 367-6510
Press spacebar to pause and continue. Press esc to stop.